LCRF has launched a funding mechanism to support research projects that facilitate or advance the understanding and characterization of pre-neoplasia or approaches for early detection of lung cancer. Work supported through this mechanism addresses important questions in non-small cell and small cell lung cancer. Areas of interest include:
- Improvements in risk stratification of patients and uptake for screening
- Identification and characterization of new biomarkers for NSCLC and SCLC • Development of predictive, diagnostic, or prognostic biomarkers
- Liquid biopsy assays and related techniques
- Genomic and histological approaches to improve early detection in tissue samples
- Novel imaging and computational modalities to identify and risk stratify pre-neoplastic lesions
- Implementation science with systematic uptake of evidence-based research findings into routine practices to improve quality and effectiveness of health services for early detection
- Studies of pre-neoplasia and progression to lung neoplasia to inform prevention strategies
- Development of pathways to increase uptake and utilization of lung cancer screening
- Epidemiology studies to identify risk factors and implementation of prevention measures
- Development of any new technologies that will aid in identifying early-stage lung cancers
Funding: $150,000
Duration: 2 years
Research Authority deadline: 3.3.26
LOI (required) due date: 10.3.26
Full proposal due date: 2.6.26
